{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:07:23Z","timestamp":1782929243819,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Strategic Cooperation Project of Luzhou Municipal People\u2019s Government-Southwest Medical University","award":["2024LZXNYDJ058"],"award-info":[{"award-number":["2024LZXNYDJ058"]}]},{"name":"the General Project of Southwest Medical University","award":["2024LCYXZX54"],"award-info":[{"award-number":["2024LCYXZX54"]}]},{"name":"the Luzhou Science and Technology Program","award":["2025RCM002"],"award-info":[{"award-number":["2025RCM002"]}]},{"name":"the Key Research and Development Program of Yibin Science and Technology Program","award":["2025SF009"],"award-info":[{"award-number":["2025SF009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01406-z","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:28:43Z","timestamp":1782926923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN\/AKT\/p53 signaling pathway"],"prefix":"10.1007","volume":"39","author":[{"given":"Zhiyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-5846","authenticated-orcid":false,"given":"Yunwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"2021","key":"1406_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2020;71(2021):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1406_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"key":"1406_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3350\/cmh.2023.0077","volume":"29","author":"S Shan","year":"2023","unstructured":"Shan S, Jia J. The clinical management of hepatocellular carcinoma in China: Progress and challenges. Clin Mol Hepatol. 2023;29:339\u201341. https:\/\/doi.org\/10.3350\/cmh.2023.0077.","journal-title":"Clin Mol Hepatol"},{"key":"1406_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bjs\/znac383","volume":"110","author":"F Primavesi","year":"2023","unstructured":"Primavesi F, St\u00e4ttner S, Maglione M. European guidelines for assessment of liver function before hepatectomy. Br J Surg. 2023;110:166\u20138. https:\/\/doi.org\/10.1093\/bjs\/znac383.","journal-title":"Br J Surg"},{"key":"1406_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s13577-024-01081-y","volume":"37","author":"R Wang","year":"2024","unstructured":"Wang R, Tang D, Ou L, Jiang J, Wu Y-N, Tian X. \u03b2-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression. Hum Cell. 2024;37:1156\u201369. https:\/\/doi.org\/10.1007\/s13577-024-01081-y.","journal-title":"Hum Cell"},{"key":"1406_CR6","unstructured":"A.L. Bras, Basic research: RNA deadenylation by CCR4\u2013NOT controls heart function, (n.d.)."},{"key":"1406_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay6912","volume":"368","author":"R Buschauer","year":"2020","unstructured":"Buschauer R, Matsuo Y, Sugiyama T, Chen Y-H, Alhusaini N, Sweet T, et al. The Ccr4-Not complex monitors the translating ribosome for codon optimality. Science. 2020;368:eaay6912. https:\/\/doi.org\/10.1126\/science.aay6912.","journal-title":"Science"},{"key":"1406_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10495-019-01550-y","volume":"24","author":"L Jing","year":"2019","unstructured":"Jing L, Zhai M-E, Cui J, Fan X-Y, Cheng Y-Y, Jiang J-L, et al. CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression. Apoptosis. 2019;24:673\u201385. https:\/\/doi.org\/10.1007\/s10495-019-01550-y.","journal-title":"Apoptosis"},{"key":"1406_CR9","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1080\/21655979.2022.2037381","volume":"13","author":"K Wei","year":"2022","unstructured":"Wei K, Gao Y, Wang B, Qu Y-X. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Bioengineered. 2022;13:5236\u201350. https:\/\/doi.org\/10.1080\/21655979.2022.2037381.","journal-title":"Bioengineered"},{"key":"1406_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.molcel.2014.03.036","volume":"54","author":"H Mathys","year":"2014","unstructured":"Mathys H, Basquin J, Ozgur S, Czarnocki-Cieciura M, Bonneau F, Aartse A, et al. Structural and biochemical insights to the role of the CCR4-NOT complex and DDX6 ATPase in microRNA repression. Mol Cell. 2014;54:751\u201365. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.036.","journal-title":"Mol Cell"},{"key":"1406_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.molcel.2014.03.034","volume":"54","author":"Y Chen","year":"2014","unstructured":"Chen Y, Boland A, Kuzuo\u011flu-\u00d6zt\u00fcrk D, Bawankar P, Loh B, Chang C-T, et al. A DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal direct links between miRNA target recognition and silencing. Mol Cell. 2014;54:737\u201350. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.034.","journal-title":"Mol Cell"},{"key":"1406_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3892\/ijo_00000760","volume":"37","author":"M Ajiro","year":"2010","unstructured":"Ajiro M, Nishidate T, Katagiri T, Nakamura Y. Critical involvement of RQCD1 in the EGFR-Akt pathway in mammary carcinogenesis. Int J Oncol. 2010;37:1085\u201393. https:\/\/doi.org\/10.3892\/ijo_00000760.","journal-title":"Int J Oncol"},{"key":"1406_CR13","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/s41467-024-45548-w","volume":"15","author":"E Benichou","year":"2024","unstructured":"Benichou E, Seffou B, Top\u00e7u S, Renoult O, Lenoir V, Planchais J, et al. The transcription factor ChREBP orchestrates liver carcinogenesis by coordinating the PI3K\/AKT signaling and cancer metabolism. Nat Commun. 2024;15:1879. https:\/\/doi.org\/10.1038\/s41467-024-45548-w.","journal-title":"Nat Commun"},{"key":"1406_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605\u201335. https:\/\/doi.org\/10.1016\/j.cell.2017.07.029.","journal-title":"Cell"},{"key":"1406_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1242\/jcs.009530","volume":"121","author":"S Maddika","year":"2008","unstructured":"Maddika S, Ande SR, Wiechec E, Hansen LL, Wesselborg S, Los M. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J Cell Sci. 2008;121:979\u201388. https:\/\/doi.org\/10.1242\/jcs.009530.","journal-title":"J Cell Sci"},{"key":"1406_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","volume":"66","author":"Z Cai","year":"2023","unstructured":"Cai Z, Wang J, Li Y, Shi Q, Jin L, Li S, et al. Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors. Sci China Life Sci. 2023;66:94\u2013109. https:\/\/doi.org\/10.1007\/s11427-021-2140-8.","journal-title":"Sci China Life Sci"},{"key":"1406_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tcb.2015.07.007","volume":"25","author":"S Dalton","year":"2015","unstructured":"Dalton S. Linking the cell cycle to cell fate decisions. Trends Cell Biol. 2015;25:592\u2013600. https:\/\/doi.org\/10.1016\/j.tcb.2015.07.007.","journal-title":"Trends Cell Biol"},{"key":"1406_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162521","volume":"11","author":"SA Kamranvar","year":"2022","unstructured":"Kamranvar SA, Rani B, Johansson S. Cell cycle regulation by integrin-mediated adhesion. Cells. 2022;11:2521. https:\/\/doi.org\/10.3390\/cells11162521.","journal-title":"Cells"},{"key":"1406_CR19","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41419-020-02921-z","volume":"11","author":"Q Chen","year":"2020","unstructured":"Chen Q, Sun X, Luo X, Wang J, Hu J, Feng Y. PIK3R3 inhibits cell senescence through p53\/p21 signaling. Cell Death Dis. 2020;11:798. https:\/\/doi.org\/10.1038\/s41419-020-02921-z.","journal-title":"Cell Death Dis"},{"key":"1406_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155652","volume":"263","author":"L Thangavelu","year":"2024","unstructured":"Thangavelu L, Altamimi ASA, Ghaboura N, Babu MA, Roopashree R, Sharma P, et al. Targeting the p53-p21 axis in liver cancer: linking cellular senescence to tumor suppression and progression. Pathol Res Pract. 2024;263:155652. https:\/\/doi.org\/10.1016\/j.prp.2024.155652.","journal-title":"Pathol Res Pract"},{"key":"1406_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s0092-8674(00)81871-1","volume":"88","author":"AJ Levine","year":"1997","unstructured":"Levine AJ. P53, the cellular gatekeeper for growth and division. Cell. 1997;88:323\u201331. https:\/\/doi.org\/10.1016\/s0092-8674(00)81871-1.","journal-title":"Cell"},{"key":"1406_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946\u201367. https:\/\/doi.org\/10.1016\/j.ccell.2024.04.009.","journal-title":"Cancer Cell"},{"key":"1406_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"key":"1406_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"key":"1406_CR25","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537.","journal-title":"Nucleic Acids Res"},{"key":"1406_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-026-01349-5","volume":"39","author":"X Chen","year":"2026","unstructured":"Chen X, Yan Z, Du X, Zhang Z, Liu X, Zhang J, et al. MKRN2 enhances hepatocellular carcinoma proliferation through the p38 MAPK pathway. Hum Cell. 2026;39:47. https:\/\/doi.org\/10.1007\/s13577-026-01349-5.","journal-title":"Hum Cell"},{"key":"1406_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040834","volume":"13","author":"X-H Song","year":"2021","unstructured":"Song X-H, Liao X-Y, Zheng X-Y, Liu J-Q, Zhang Z-W, Zhang L-N, et al. Human Ccr4 and Caf1 Deadenylases Regulate Proliferation and Tumorigenicity of Human Gastric Cancer Cells via Modulating Cell Cycle Progression. Cancers (Basel). 2021;13:834. https:\/\/doi.org\/10.3390\/cancers13040834.","journal-title":"Cancers (Basel)"},{"key":"1406_CR28","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1038\/s41388-018-0603-7","volume":"38","author":"Y-T Shirai","year":"2019","unstructured":"Shirai Y-T, Mizutani A, Nishijima S, Horie M, Kikuguchi C, Elisseeva O, et al. CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development. Oncogene. 2019;38:2580\u201394. https:\/\/doi.org\/10.1038\/s41388-018-0603-7.","journal-title":"Oncogene"},{"key":"1406_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101470","volume":"11","author":"J Lee","year":"2019","unstructured":"Lee J, Jung JH, Hwang J, Park JE, Kim J-H, Park WY, et al. CNOT2 is critically involved in atorvastatin induced apoptotic and autophagic cell death in non-small cell lung cancers. Cancers (Basel). 2019;11:1470. https:\/\/doi.org\/10.3390\/cancers11101470.","journal-title":"Cancers (Basel)"},{"key":"1406_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"1406_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biom9040153","volume":"9","author":"A Papa","year":"2019","unstructured":"Papa A, Pandolfi PP. The PTEN\u2212PI3K Axis in Cancer. Biomolecules. 2019;9:153. https:\/\/doi.org\/10.3390\/biom9040153.","journal-title":"Biomolecules"},{"key":"1406_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Hu K, Cai X, Yang B, He Q, Wang J, et al. Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B. 2022;12:18\u201332. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.023.","journal-title":"Acta Pharm Sin B"},{"key":"1406_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","volume":"59","author":"S Revathidevi","year":"2019","unstructured":"Revathidevi S, Munirajan AK. Akt in cancer: Mediator and more. Semin Cancer Biol. 2019;59:80\u201391. https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.002.","journal-title":"Semin Cancer Biol"},{"key":"1406_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Bode AM, Dong Z, Lee M-H. AKT as a therapeutic target for cancer. Cancer Res. 2019;79:1019\u201331. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2738.","journal-title":"Cancer Res"},{"key":"1406_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"key":"1406_CR36","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-24-1846","volume":"84","author":"E Sementino","year":"2024","unstructured":"Sementino E, Hassan D, Bellacosa A, Testa JR. AKT and the hallmarks of cancer. Cancer Res. 2024;84:4126\u201339. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-1846.","journal-title":"Cancer Res"},{"key":"1406_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00860-9","volume":"29","author":"P-J Tsai","year":"2022","unstructured":"Tsai P-J, Lai Y-H, Manne RK, Tsai Y-S, Sarbassov D, Lin H-K. Akt: a key transducer in cancer. J Biomed Sci. 2022;29:76. https:\/\/doi.org\/10.1186\/s12929-022-00860-9.","journal-title":"J Biomed Sci"},{"key":"1406_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari R, Jat P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. 2021;9:645593. https:\/\/doi.org\/10.3389\/fcell.2021.645593.","journal-title":"Front Cell Dev Biol"},{"key":"1406_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153\u201366. https:\/\/doi.org\/10.1038\/nrc2602.","journal-title":"Nat Rev Cancer"},{"key":"1406_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.semcdb.2020.04.003","volume":"107","author":"N Palmer","year":"2020","unstructured":"Palmer N, Kaldis P. Less-well known functions of cyclin\/CDK complexes. Semin Cell Dev Biol. 2020;107:54\u201362. https:\/\/doi.org\/10.1016\/j.semcdb.2020.04.003.","journal-title":"Semin Cell Dev Biol"},{"key":"1406_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.774845","volume":"9","author":"R Fagundes","year":"2021","unstructured":"Fagundes R, Teixeira LK. Cyclin E\/CDK2: DNA replication, replication stress and genomic instability. Front Cell Dev Biol. 2021;9:774845. https:\/\/doi.org\/10.3389\/fcell.2021.774845.","journal-title":"Front Cell Dev Biol"},{"key":"1406_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137:413\u201331. https:\/\/doi.org\/10.1016\/j.cell.2009.04.037.","journal-title":"Cell"},{"key":"1406_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095005","volume":"23","author":"N Koo","year":"2022","unstructured":"Koo N, Sharma AK, Narayan S. Therapeutics targeting p53-MDM2 interaction to induce cancer cell death. Int J Mol Sci. 2022;23:5005. https:\/\/doi.org\/10.3390\/ijms23095005.","journal-title":"Int J Mol Sci"},{"key":"1406_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102230","volume":"72","author":"K Kwan","year":"2023","unstructured":"Kwan K, Castro-Sandoval O, Gaiddon C, Storr T. Inhibition of p53 protein aggregation as a cancer treatment strategy. Curr Opin Chem Biol. 2023;72:102230. https:\/\/doi.org\/10.1016\/j.cbpa.2022.102230.","journal-title":"Curr Opin Chem Biol"},{"key":"1406_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s13577-025-01201-2","volume":"38","author":"P Wijayasiri","year":"2025","unstructured":"Wijayasiri P, Astbury S, Needham G, Kaye P, Bhat M, Piccinini AM, et al. Role of hepatocellular senescence in the development of hepatocellular carcinoma and the potential for therapeutic manipulation. Hum Cell. 2025;38:70. https:\/\/doi.org\/10.1007\/s13577-025-01201-2.","journal-title":"Hum Cell"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01406-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01406-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01406-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:28:48Z","timestamp":1782926928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01406-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01406-z","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: the Clinical Research Ethics Committee of Southwest Medical University Affiliated Hospital (Ethics Number: KY2025266).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the Registration No. of the study\/trial"}},{"value":"The Ethics Committee of Southwest Medical University (Ethics No.: swmu20250066).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}],"article-number":"96"}}